0001179110-12-009715.txt : 20120606 0001179110-12-009715.hdr.sgml : 20120606 20120606162348 ACCESSION NUMBER: 0001179110-12-009715 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120604 FILED AS OF DATE: 20120606 DATE AS OF CHANGE: 20120606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-274-8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rieder Wendy E CENTRAL INDEX KEY: 0001325714 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 12892306 MAIL ADDRESS: STREET 1: C/O SYNTA PHARMACEUTICALS CORP. STREET 2: 45 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 edgar.xml FORM 4 - X0305 4 2012-06-04 0 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001325714 Rieder Wendy E C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 VP, IP and Legal, Gen. Counsel Common Stock 2012-06-04 4 M 0 7170 2.49 A 26993 D Common Stock 2012-06-04 4 S 0 7170 5.50 D 19823 D Employee Stock Option (Right to Buy) 2.49 2012-06-04 4 M 0 7170 0 D 2019-04-13 Common Stock 7170 23700 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2011. The option vested as to 50% of the shares on January 13, 2010 and as to the remaining 50% of the shares on October 13, 2010. /s/ Ann Margaret Eames, Attorney-in-Fact 2012-06-06